Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Jennifer Riter
Assessing And Navigating Testing For Parenteral Packaging And Delivery Systems: Performance Testing
By Jennifer Riter It is important to consider the drug product and device functionality early in the development process. In addition, as containment system, delivery system, or combination product, are refined through development, device functionality must be continually evaluated. There are many aspects to consider when developing a sound approach to performance testing to qualify packaging and delivery systems, and combination products.
10.31.23 -- EU Medtech Labeling Compliance & The Competitive Advantage Of A Digitalized Process
Get the latest industry news and expert insights delivered straight to your inbox! Newsletter | October 31, 2023 In the medtech industry, where time and regulatory compliance are crucial, optimizing and digitalizing your labeling processes are essential for bringing medical devices to market quickly and play a vital role in keeping products available to patients and healthcare providers in the EU.
Jennifer Riter, Author at ONdrugDelivery
Jennifer Riter is Senior Director, Business and Technical Operations for the Services and Solutions organisation at West Pharmaceutical Services. Her experience spans 27 years of West’s components, containment and delivery systems, with hands-on experience of providing technical support and analytical solutions to the company’s multinational customers. She has also spoken at several symposiums on analytical testing of parenteral packaging components, devices and combination products.
SUCCESSFUL INDUSTRIALISATION REQUIRES SOLID FOUNDATIONS
To Issue 150 Citation: Riter J, Morgan V, “Successful Industrialisation Requires Solid Foundations.” ONdrugDelivery, Issue 150 (Jul 2023), pp 19–22. Jennifer Riter and Victoria Morgan discuss the importance of choosing the right containment system at the start for successful industrialisation of an injectable drug product.
Industrialising Drug Delivery150
Inside the magazine Top This website uses functional cookies (but not advertising cookies). View our Privacy Policy.
Demystifying Performance Testing: Strategies To Qualify Combination Products
By Daniel Bantz, Jennifer L. Riter, T. Page McAndrew; West Pharmaceutical Services, Inc. Demonstration of fit-for-purpose for a drug-device combination product requires demonstration of system performance that meets regulatory requirements. This article presents a best practice strategy for performance testing. It starts with a thorough understanding of applicable regulations and guidances.
Hot Tech (MD&M West): EPRs in wearable medtech
MD&M West takes place annually in Anaheim. The event brings together premier MedTech engineers, and thinkers. In this special “hot tech” section, we highlight exciting research, people, and technology shaping the industry’s future. We caught up with Jennifer Riter, Senior Director, Business and Technical Operations for West Pharmaceutical. Do you, or does your company have some hot tech to share? Get in touch! Q&A With Jennifer Riter, West Pharmaceutical, Inc.
Demystifying Performance Testing: Strategies To Qualify Combination Products
By Daniel Bantz, Jennifer L. Riter, T. Page McAndrew; West Pharmaceutical Services, Inc. Demonstration of fit-for-purpose for a drug-device combination product requires demonstration of system performance that meets regulatory requirements. This article presents a best practice strategy for performance testing. It starts with a thorough understanding of applicable regulations and guidances.
Demystifying Performance Testing: Strategies To Qualify Combination Products
By Daniel Bantz, Jennifer L. Riter, T. Page McAndrew; West Pharmaceutical Services, Inc. Demonstration of fit-for-purpose for a drug-device combination product requires demonstration of system performance that meets regulatory requirements. This article presents a best practice strategy for performance testing. It starts with a thorough understanding of applicable regulations and guidances.
11.11.21 -- Innovation Needed In CAR-T Manufacturing
Article | By Susan Neadle, Johnson & Johnson, Inc., Jennifer L. Riter and T. Page McAndrew, West Pharmaceutical Services, Inc. Drug-device combination products are rapidly increasing in use, due to their numerous benefits. This article is a review of achieving performance and regulatory compliance for their successful development and commercialization.
Demystifying Performance Testing: Strategies To Qualify Combination Products
By Daniel Bantz, Jennifer L. Riter, T. Page McAndrew; West Pharmaceutical Services, Inc. Demonstration of fit-for-purpose for a drug-device combination product requires demonstration of system performance that meets regulatory requirements. This article presents a best practice strategy for performance testing. It starts with a thorough understanding of applicable regulations and guidances.
Do extractables and leachables affect combination product development?
Jennifer Riter, senior director, analytical services for West Pharmaceutical Services, explores the impact of extractables and leachables on combination product development. Extractables and leachables analysis is an essential and integral part of qualifying combination product packaging and delivery systems during drug development.
Assessing And Navigating Testing For Parenteral Packaging And Delivery Systems Container Closure Integrity
By Jennifer Riter Container Closure Integrity (CCI) is a key area that needs to be evaluated in the development phase of drug products. CCI is defined as the ability of a package to prevent product loss, to block the ingress of microorganisms, and to limit entry of detrimental gases or other substances over the shelf life – ensuring that the drug product meets all necessary safety and quality standards.
Assessing And Navigating Testing For Parenteral Packaging And Delivery Systems Performance Testing
By Jennifer Riter It is important to consider the drug product and device functionality early in the development process. In addition, as containment system, delivery system, or combination product, are refined through development, device functionality must be continually evaluated. There are many aspects to consider when developing a sound approach to performance testing to qualify packaging and delivery systems, and combination products.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Jennifer
Contact Jennifer, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack